Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

Published 2015 View Full Article

Authors

Keywords

Molecular targeted drug, Erlotinib, Endometrial cancer, EGFR

Journal

BMC CANCER

Volume 15, Issue 1, Pages -

Publisher

Springer Nature

Online

2015-12-17

DOI

10.1186/s12885-015-1975-5

References

View 9 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started